Markets open in balance and then slide into the red as Federal Reserve fed fears add to Iran and China trade fears. A few cherry picks in stocks in biotech, frontier markets and buying back US media. A

Biogen/Eisai to present updated subgroup analyses on their Phase 2 study looking at their Alzheimer's medicine, BAN2401. This antibody binds to amyloid beta protofibrils, reducing plaques in the brain.

Today I break down Alzheimer's disease and the latest Biogen Phase 2 trial results. This is not investment advice

Sell bull put credit spread option for $BIIB, 04/26/18 free option pick #BIIB #stocks #trading #daytraders #options #OptionsTrading #nasdaq

Biogen could potentially set up here for a rebound higher from very oversold conditions.